🇺🇸 Conventional therapy of antiphospholipis syndrome in United States

Conventional therapy of antiphospholipis syndrome (Conventional therapy of antiphospholipis syndrome) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Conventional therapy of antiphospholipis syndrome in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Conventional therapy of antiphospholipis syndrome approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Conventional therapy of antiphospholipis syndrome in United States?

Tanta University is the originator. The local marketing authorisation holder may differ — check the official source linked above.